Menu
Your Cart

Ofloksatsin-Pharmex cap. eye. 3mg/ml fl. 5 ml

Ofloksatsin-Pharmex cap. eye. 3mg/ml fl. 5 ml
Ofloksatsin-Pharmex cap. eye. 3mg/ml fl. 5 ml
Ofloksatsin-Pharmex cap. eye. 3mg/ml fl. 5 ml
Ofloksatsin-Pharmex cap. eye. 3mg/ml fl. 5 ml
Ofloksatsin-Pharmex cap. eye. 3mg/ml fl. 5 ml
$18.44
  • Stock: In Stock
  • Model: 179602

0% Customers recommend this product

  • 5 Awesome
    0%
  • 4 Great
    0%
  • 3 Average
    0%
  • 2 Bad
    0%
  • 1 Poor
    0%

Reviews Over Ofloksatsin-Pharmex cap. eye. 3mg/ml fl. 5 ml

  • (0)

Total Reviews (0)
click here write review to add review for this product.



Description

Ofloksatsin-Pharmex – the means applied in ophthalmology to topical treatment of external eye infections (such as conjunctivitis and keratitis) at the adults and children called by the microorganisms sensitive to an ofloksatsin.

Structure

  • active ingredient: ofloxacin;
  • ofloxacin of 3 mg contains
  • 1 ml of solution;
  • other components: a benzalkoniya chloride, sodium chloride, sodium hydroxide and/or Acidum hydrochloricum (for correction rn), water for injections.

Contraindication

Hypersensitivity to any of medicine components, other hinolona.

Route of administration Drug is intended to

by

only for topical administration in eyes.

First 2 days dig in

on 1–2 drops each 2–4 hours, then – 4 times a day. Duration of treatment should not exceed 10 days.

Feature of application

At emergence of allergic reaction to Ofloksatsin-Pharmex intake of medicine should be stopped. Drug with care is used to the patients who were earlier showing sensitivity to other antibacterial agents of group of hinolon.

Pregnant

As system ftorkhinolona are capable to cause an arthropathy in seniors, it is not necessary to use medicament during pregnancy.

Children Safety and efficiency at children till 1 year are not established to

by

.

Ofloksatsin-Pharmex, a drop eye, children can appoint of 1 year.

Drivers

Use of the medicine Ofloksatsin-Pharmex, eye drops, does not influence speed of response at the patient.

by

After instillation medicine in a conjunctival sac of an eye the illegibility of sight within several minutes can be observed. So far indistinct sight, patients should abstain from control of motor transport or work with other mechanisms.

Overdose

in case of overdose should perform symptomatic treatment. As extension of an interval of QT is possible, it is necessary to carry out ECG monitoring.

Side effects

from the immune system: reactions of hypersensitivity, including manifestations and symptoms of an allergy (for example, an itch and a century) and anaphylactic reactions (for example a Quincke's disease, short wind, an acute anaphylaxis, orofaringealny hypostasis, edema of face and language).

from nervous system: dizziness.

from organs of sight: irritation of eyes, discomfort in eyes, the keratitis, conjunctivitis, misting of sight, photophobia, swelled an eye, feeling of a foreign matter, the raised dacryagogue, dryness of an eye, eye pain, eye hyperaemia, periorbital hypostasis (including the century swelled).

Storage conditions

to Store

in original packing at a temperature not above 25 °C. To store out of children's reach.

Specifications

Characteristics
Active ingredients Ofloxacin
Amount of active ingredient 3 mg/ml
Applicant Pharmex Group
Code of automatic telephone exchange S01AE01 Ofloxacin
Interaction with food It doesn't matter
Light sensitivity Not sensitive
Market status Generic-generic
Origin Chemical
Prescription status According to the prescription
Primary packing bottle
Producer LTD COMPANY PHARMEX GROUP
Quantity in packing 1 bottle
Release form eye drops
Route of administration Eye
Sign Domestic
Storage temperature from 5 °C to 25 °C
Trade name Ofloxacin